Back
Ocular Therapeutix Vs. 4D Molecular Therapeutics Industry Stock Comparison
Buy
63
OCUL
Ocular Therapeutix
Last Price:
9.56
Seasonality Move:
41.77%
Sell
46
FDMT
4D Molecular Therapeutics
Last Price:
6.90
Seasonality Move:
19.19%
Buy
63
Ocular Therapeutix (OCUL)
is a Buy
Is Ocular Therapeutix a Buy, Sell or Hold?
- The current Ocular Therapeutix [OCUL] share price is $9.44. The Score for OCUL is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- OCUL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $6.90. The Score for FDMT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OCUL Stock Price Chart
What is Ocular Therapeutix's stock price today?
-
The Ocular Therapeutix share price today is $9.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCUL is experiencing slight buying pressure.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $6.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing selling pressure, which indicates risk of future bearish movement.
OCUL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 46.57 | Sell |
Chaikin Money Flow: | 303401 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
FDMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 36.39 | Sell |
Chaikin Money Flow: | -516596 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.25 - 8.31) | Sell |
Bollinger Bands (100): | (8.01 - 15.43) | Sell |
OCUL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.53 | Sell |
20-day SMA: | 9.46 | Sell |
50-day SMA: | 10.02 | Sell |
200-day SMA: | 8.23 | Buy |
8-day EMA: | 9.46 | Sell |
20-day EMA: | 9.61 | Sell |
50-day EMA: | 9.65 | Sell |
200-day EMA: | 8.16 | Buy |
FDMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.16 | Sell |
20-day SMA: | 7.69 | Sell |
50-day SMA: | 8.31 | Sell |
200-day SMA: | 18.82 | Sell |
8-day EMA: | 7.22 | Sell |
20-day EMA: | 7.6 | Sell |
50-day EMA: | 8.96 | Sell |
200-day EMA: | 15.03 | Sell |
Ocular Therapeutix Earnings Growth & OCUL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.13 per share, and an increase next year of $0.04 per share.
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and a decrease next year of $0.69 per share.
Ocular Therapeutix Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
4D Molecular Therapeutics Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |